Curis
CRIS
#10233
Rank
S$19.36 M
Marketcap
S$1.50
Share price
-10.08%
Change (1 day)
-68.88%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): S-$4.87

According to Curis's latest financial reports the company's current EPS (TTM) is S-$4.74. In 2024 the company made an earnings per share (EPS) of S-$9.08 an increase over its 2023 EPS that were of S-$11.65.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.87-46.31%
2024S-$9.08-22.06%
2023S-$11.65-26.25%
2022S-$15.7922.3%
2021S-$12.91-25.37%
2020S-$17.30-30.93%
2019S-$25.05-2.02%
2018S-$25.57
2016S-$58.11-10%
2015S-$64.57138.1%
2014S-$27.1240%
2013S-$19.37-25%
2012S-$25.8366.67%
2011S-$15.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
S$3.07-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.82-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$4.36-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.22-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$3.84-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$14.52 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA